Intravesical sequential gemcitabine/docetaxel for non-muscle invasive bladder cancer: tips and tricks for better efficacy and tolerability

被引：0
|
作者：
Abou Chakra, Mohamad [1 ]
Moussa, Mohamad [2 ]
O'Donnell, Michael A. [1 ]
机构：
[1] Univ IA, Dept Urol, Iowa City, IA 52242 USA
[2] Lebanese Univ, Al Zahraa Hosp, Dept Urol, Beirut, Lebanon
来源：
JOURNAL OF CHEMOTHERAPY | 2024年 / 36卷 / 08期
关键词：
RESCUE THERAPY; DOCETAXEL;
D O I：
10.1080/1120009X.2024.2325765
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：694 / 697
页数：4
相关论文
共 50 条
  • [21] Induction and maintenance of sequential intravesical gemcitabine/docetaxel for intermediate and high-risk non-muscle invasive bladder cancer with different dosage protocols
    Ben-David, Reuben
    Tillu, Neeraja
    Alerasool, Parissa
    Bieber, Christine
    Ranti, Daniel
    Tolani, Serena
    Eisenhauer, Justin
    Chung, Rainjade
    Lavallee, Etienne
    Waingankar, Nikhil
    Attalla, Kyrollis
    Wiklund, Peter
    Mehrazin, Reza
    Anderson, Christopher B.
    Sfakianos, John P.
    WORLD JOURNAL OF UROLOGY, 2024, 42 (01)
  • [22] EARLY CLINICAL EXPERIENCE WITH SEQUENTIAL INTRAVESICAL GEMCITABINE-DOCETAXEL FOR TREATMENT-NAIVE HIGH RISK NON-MUSCLE INVASIVE BLADDER CANCER
    Manuel, Refugia Justin
    Emily, Roebuck
    Parth, Thakker U.
    Ashok, Hemal
    Matvey, Tsivian
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2024, 42 : S49 - S50
  • [23] Intravesical gemcitabine therapy for non-muscle invasive bladder cancer (NMIBC): a systematic review
    Shelley, Mike D.
    Jones, Gabriel
    Cleves, Anne
    Wilt, Timothy J.
    Mason, Malcolm D.
    Kynaston, Howard G.
    BJU INTERNATIONAL, 2012, 109 (04) : 496 - 505
  • [24] Multi-institutional analysis of sequential intravesical gemcitabine and mitomycin C chemotherapy for non-muscle invasive bladder cancer
    Lightfoot, Andrew J.
    Breyer, Benjamin N.
    Rosevear, Henry M.
    Erickson, Bradley A.
    Konety, Badrinath R.
    O'Donnell, Michael A.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2014, 32 (01) : 35.e15 - 35.e19
  • [25] Efficacy of combined intravesical immunotherapy and chemotherapy for non-muscle invasive bladder cancer
    Hilton, William M.
    Ercole, Barbara
    Parekh, Dipen J.
    Sonpavde, Guru
    Ghosh, Rita
    Svatek, Robert S.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2011, 11 (06) : 949 - 957
  • [26] Intravesical Gemcitabine and Docetaxel Therapy for BCG-Naïve Patients: A Promising Approach to Non-Muscle Invasive Bladder Cancer
    Bakula, Mirko
    Hudolin, Tvrtko
    Knezevic, Nikola
    Zimak, Zoran
    Andelic, Jerko
    Juric, Ilija
    Gamulin, Marija
    Gnjidic, Milena
    Kastelan, Zeljko
    LIFE-BASEL, 2024, 14 (07):
  • [27] LONG-TERM FOLLOW-UP OF INTRAVESICAL GEMCITABINE AND DOCETAXEL AS RESCUE THERAPY FOR NON-MUSCLE INVASIVE BLADDER CANCER
    Chevuru, Phani T.
    McElree, Ian M.
    Martin, Alexander C.
    Richards, Jordan R.
    Mott, Sarah L.
    Gellhaus, Paul T.
    Nepple, Kenneth G.
    Steinberg, Ryan L.
    O'Donnell, Michael A.
    Packiam, Vignesh T.
    JOURNAL OF UROLOGY, 2022, 207 (05): : E257 - E258
  • [28] INTRAVESICAL GEMCITABINE VERSUS INTRAVESICAL BACILLUS CALMETTE-GUERIN FOR THE TREATMENT OF NON-MUSCLE INVASIVE BLADDER CANCER: AN EVALUATION OF EFFICACY AND TOLERANCE
    Prasanna, T.
    Kuo, J. C.
    Hickie, M.
    Sim, B. W. C.
    Pranavan, G.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2014, 10 : 35 - 35
  • [29] Intravesical Gemcitabine versus Intravesical Bacillus Calmette-Guerin for the Treatment of Non-Muscle Invasive Bladder Cancer: An Evaluation of Efficacy and Toxicity
    Prasanna, Thiru
    Craft, Paul
    Balasingam, Gayathri
    Haxhimolla, Hodo
    Pranavan, Ganes
    FRONTIERS IN ONCOLOGY, 2017, 7
  • [30] Real-word efficacy of adjuvant single-agent intravesical gemcitabine for non-muscle invasive bladder cancer
    Abou Chakra, Mohamad
    Packiam, Vignesh T.
    O'Donnell, Michael A.
    EXPERT OPINION ON PHARMACOTHERAPY, 2023, 24 (18) : 2081 - 2091
12345